Selling And Administration Expenses 更改
Acadia Pharmaceuticals USD 107.99M 3.47M 2024-03
Alnylam Pharmaceuticals USD 210.8M 12.67M 2024-03
Amgen USD 1.81B 44M 2024-03
Biogen USD 581.5M 27M 2024-03
BioMarin Pharmaceutical USD 225.91M 49.12M 2024-03
Cytokinetics USD 45.5M 1.39M 2024-03
Daiichi Sankyo JPY 160.33B 19.29B 2023-12
Gilead Sciences USD 1.38B 233M 2024-03
Incyte USD 300.3M 6.44M 2024-03
Ionis Pharmaceuticals USD 52.64M 18.37M 2024-03
Ironwood Pharmaceuticals USD 37.6M 1.06M 2024-03
Novartis USD 2.84B 604M 2024-03
Pfizer USD 3.5B 976M 2024-03
PTC Therapeutics USD 73.27M 3.02M 2024-03
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 127M 6.11M 2024-03
TG Therapeutics USD 34.58M 3.43M 2024-03
Ultragenyx Pharmaceutical USD 78.16M 1.33M 2024-03
Vertex Pharmaceuticals USD 342.7M 78.9M 2024-03
Xencor USD 13.79M 1.69M 2024-03



PTC Therapeutics 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.